Similar articles

• Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival.

  Mavligit GM, Gutterman JU, Malahy MA, Burgess MA, McBride CM, Jubert A, Hersh EM. Mavligit GM, et al. Cancer. 1977 Nov;40(5 Suppl):2726-30. doi: 10.1002/1097-0142(197711)40:5+<2726::aid-cncr2820400947>3.0.co;2-l. Cancer. 1977. PMID: 922710
• Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results.

  Mavligit GM, Gutterman JU, Burgess MA, Khankhanian N, Seibert GB, Speer JF, Reed RC, Jubert AV, Martin RC, McBride CM, Copeland EM, Gehan EA, Hersh EM. Mavligit GM, et al. Cancer. 1975 Dec;36(6 Suppl):2421-7. doi: 10.1002/1097-0142(197512)36:6<2421::aid-cncr2820360623>3.0.co;2-2. Cancer. 1975. PMID: 1212660
• Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG).

  Robinson E, Bartal A, Cohen Y, Haim N, Mohilever J, Mekori T. Robinson E, et al. Cancer Chemother Pharmacol. 1982;8(1):35-40. doi: 10.1007/BF00292869. Cancer Chemother Pharmacol. 1982. PMID: 7094200 Clinical Trial.
• Colorectal cancer. Recent developments and continuing controversies.

  Lee MW. Lee MW. Postgrad Med. 1992 Jan;91(1):153-5, 159-60. doi: 10.1080/00325481.1992.11701172. Postgrad Med. 1992. PMID: 1728769 Review.
• Chemotherapy and chemoimmunotherapy of colorectal cancer. Role of the carcinoembryonic antigen.

  Valdivieso M, Mavligit GM. Valdivieso M, et al. Surg Clin North Am. 1978 Jun;58(3):619-31. doi: 10.1016/s0039-6109(16)41543-4. Surg Clin North Am. 1978. PMID: 354057 Review.